Allogeneic Transplantation
Mostrando 13-24 de 290 artigos, teses e dissertações.
-
13. Measurement of oral health quality of life among patients who underwent haematopoietic stem-cell transplantation
Abstract Oral mucositis is a painful condition that occurs in patients who have undergone haematopoietic stem-cell transplantation (HSCT) and has a huge impact on their quality of life. The objective of this study was to examine the extent to which interleukin-6 (IL-6) and tumour necrosis factor alpha (TNF-α) are associated with oral health quality of life
Braz. oral res.. Publicado em: 23/07/2018
-
14. Donor characteristics and hematopoietic stem cell transplantation outcome: experience of a single center in Southern Brazil
ABSTRACT Background: Hematopoietic stem cell transplantation is a curative treatment for many patients with hematological disorders. Donor–recipient genetic disparity, especially involving the human leukocyte antigen system is a critical factor for transplant outcome. Objective: To evaluate retrospectively donor characteristics and correlations with the
Hematol., Transfus. Cell Ther.. Publicado em: 2018-06
-
15. Pre-sarcopenia and bone mineral density in adults submitted to hematopoietic stem cell transplantation
Abstract Background: The aim of this study was to evaluate the prevalence of pre-sarcopenia and bone mineral density after hematopoietic stem cell transplantation. Methods: The study group consisted of over 18-year-old patients who had been submitted to allogeneic transplantation at least one year previously. Patients and healthy controls were matched by s
Rev. Bras. Hematol. Hemoter.. Publicado em: 2017-12
-
16. The need for endodontic treatment and systemic characteristics of hematopoietic stem cell transplantation patients
Abstract The aim of this study is to investigate the relationship between the epidemiological and clinical profiles of patients before and after hematopoietic stem cell transplantation (HSCT) and the need for endodontic treatment. The subjects included 188 individuals enrolled in the dental care program for transplanted patients of the School of Dentistry, F
Braz. oral res.. Publicado em: 03/07/2017
-
17. Nutritional status and hyperglycemia in the peritransplant period: a review of associations with parenteral nutrition and clinical outcomes
ABSTRACT Hematopoietic stem cell transplantation is an established treatment option for various hematological diseases. This therapy involves complex procedures and is associated with several systemic complications. Due to the toxic effects of the conditioning regimen used in allogeneic transplantations, patients frequently suffer from severe gastrointestina
Rev. Bras. Hematol. Hemoter.. Publicado em: 2017-06
-
18. Detection of Human Adenovirus (species-C, -D and -F) in an allogeneic stem cell transplantation recipient: a case report
Rev. Bras. Hematol. Hemoter.. Publicado em: 2017-03
-
19. Secondary myeloid neoplasms: bone marrow cytogenetic and histological features may be relevant to prognosis
Abstract Background: Secondary myeloid neoplasms comprise a group of diseases arising after chemotherapy, radiation, immunosuppressive therapy or from aplastic anemia. Few studies have addressed prognostic factors in these neoplasms. Method: Forty-two patients diagnosed from 1987 to 2008 with secondary myeloid neoplasms were retrospectively evaluated conce
Rev. Bras. Hematol. Hemoter.. Publicado em: 2017-03
-
20. Alemtuzumab as graft-versus-host disease (GVHD) prophylaxis strategy in a developing country: lower rate of acute GVHD, increased risk of cytomegalovirus reactivation
Acute graft-versus-host disease (aGVHD) and cytomegalovirus reactivation are important complications after allogeneic stem cell transplantation (alloHSCT). Here, we evaluated the impact of treatment with alemtuzumab on the occurrence of aGVHD, cytomegalovirus reactivation and survival after alloHSCT. This was a prospective cohort study conducted at the allo-
Braz J Med Biol Res. Publicado em: 09/02/2017
-
21. Outcomes of allogeneic hematopoietic stem cell transplantation for lymphomas: a single-institution experience
ABSTRACT Introduction: Allogeneic hematopoietic stem cell transplantation offers the opportunity for extended survival in patients with Hodgkin's and non-Hodgkin lymphomas who relapsed after, or were deemed ineligible for, autologous transplantation. This study reports the cumulative experience of a single center over the past 14 years aiming to define the
Rev. Bras. Hematol. Hemoter.. Publicado em: 2016-12
-
22. Allogeneic hematopoietic stem cell transplantation in patients with advanced indolent lymphoproliferative disorders
ABSTRACT BACKGROUND: The role of allogeneic hematopoietic stem cell transplantation for advanced indolent lymphoproliferative disorders remains to be established. OBJECTIVE: This paper aims to describe the results of allogeneic hematopoietic stem cell transplantation in patients with advanced indolent lymphoproliferative disorders. METHODS: This article
Rev. Bras. Hematol. Hemoter.. Publicado em: 2016-06
-
23. Nutritional assessment as predictor of complications after hematopoietic stem cell transplantation
ABSTRACT Introduction: Nutritional support is pivotal in patients submitted to hematopoietic stem cell transplantation. Nutritional status has been associated with time of engraftment and infection rates. In order to evaluate the association between nutritional parameters and clinical outcomes after transplantation a cohort of transplant patients was retros
Rev. Bras. Hematol. Hemoter.. Publicado em: 2016-02
-
24. Clostridium difficile infection in Chilean patients submitted to hematopoietic stem cell transplantation
ABSTRACT Introduction: Patients submitted to hematopoietic stem cell transplantation have an increased risk of Clostridium difficile infection and multiple risk factors have been identi- fied. Published reports have indicated an incidence from 9% to 30% of transplant patients however to date there is no information about infection in these patients in Ch
Rev. Bras. Hematol. Hemoter.. Publicado em: 2015-12